Gil Omenn

Gilbert S. Omenn, M.D., Ph.D. is the Harold T. Shapiro Distinguished University Professor of Internal Medicine, Human Genetics, and Public Health at the University of Michigan.[1] He is the director of the UM Center for Computational Medicine & Bioinformatics.

He served as Executive Vice President for Medical Affairs and as Chief Executive Officer of the University of Michigan Health System from 1997 to 2002. He was formerly Dean of the School of Public Health, and Professor of Medicine and Environmental Health, University of Washington, Seattle. He served as Associate Director, Office of Science and Technology Policy, and Associate Director, Office of Management and Budget, in the Executive Office of the President in the Carter Administration.[2]

He is a member of the Council and leader of the Plasma Proteome Project for the international Human Proteome Organization. He is Past President (2005-2006) and Past Chairman of the Board (2006-2007) of the American Association for the Advancement of Science (AAAS). He is a longtime director of Amgen Inc. and of Rohm & Haas Company. He is also on the advisory board of NextServices.

He received a B.A. from Princeton University, an M.D. from Harvard Medical School and a Ph.D. in genetics from the University of Washington.[1]

References

  1. 1 2 faculty page at the University of Michigan
  2. ↑ Former U-M Health System CEO: Health care reform will come this year, MLive.com, March 31, 2009
This article is issued from Wikipedia - version of the Thursday, April 28, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.